Selective cyclooxygenase-2 inhibition prevents bone resorption

Detalhes bibliográficos
Autor(a) principal: Nassar, Carlos Augusto
Data de Publicação: 2005
Outros Autores: Nassar, Patrícia Oehlmeyer, Nassar, Patrícia Maria, Spolidorio, Luis Carlos [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1590/S1806-83242005000100007
http://hdl.handle.net/11449/213128
Resumo: The aim of the present work was to evaluate the effect of a selective cyclooxygenase-2 (COX-2) inhibitor (meloxicam) on the alveolar bone loss progression in experimentally induced periodontitis. Forty (40) Wistar rats were separated into 8 experimental groups (n = 5). Cotton ligatures were placed at the gingival margin level of the lower right first molars of some rats. Four groups were treated for 5 or 15 days with an oral dose of 15 mg/kg of body weight/day of the selective COX-2 inhibitor. The other groups were used as positive control (sham) or negative control in each experimental period. Standardized digital radiographs were taken after sacrifice at 5 and 15 days to measure the amount of bone loss at the mesial root surface of the first molar tooth in each rat. The treatment with meloxicam did not induce weight alteration or other visible systemic manifestations. One way analysis of variance (ANOVA) indicated that groups treated with meloxicam, after 5 days, had significantly less alveolar bone loss (p < 0.05) when compared with control groups. On the other hand, no significant differences in bone loss were observed after 15 days of treatment with meloxicam. These data provide evidence that systemic therapy with meloxicam can modify the progression of experimentally induced periodontitis in rats during the initial experimental period.
id UNSP_4c83c120abdf700654b0631b8abe53bf
oai_identifier_str oai:repositorio.unesp.br:11449/213128
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Selective cyclooxygenase-2 inhibition prevents bone resorptionInibidor seletivo de cicloxigenase-2 prevenindo reabsorção ósseaAlveolar bone lossAnti-inflammatory agents, non-steroidalCyclooxygenase inhibitorsPeriodontitisRadiography, dentalPerda óssea alveolarAntiinflamatórios não esteróidesInibidores de ciclooxigenasePeriodontiteRadiografia dentáriaThe aim of the present work was to evaluate the effect of a selective cyclooxygenase-2 (COX-2) inhibitor (meloxicam) on the alveolar bone loss progression in experimentally induced periodontitis. Forty (40) Wistar rats were separated into 8 experimental groups (n = 5). Cotton ligatures were placed at the gingival margin level of the lower right first molars of some rats. Four groups were treated for 5 or 15 days with an oral dose of 15 mg/kg of body weight/day of the selective COX-2 inhibitor. The other groups were used as positive control (sham) or negative control in each experimental period. Standardized digital radiographs were taken after sacrifice at 5 and 15 days to measure the amount of bone loss at the mesial root surface of the first molar tooth in each rat. The treatment with meloxicam did not induce weight alteration or other visible systemic manifestations. One way analysis of variance (ANOVA) indicated that groups treated with meloxicam, after 5 days, had significantly less alveolar bone loss (p < 0.05) when compared with control groups. On the other hand, no significant differences in bone loss were observed after 15 days of treatment with meloxicam. These data provide evidence that systemic therapy with meloxicam can modify the progression of experimentally induced periodontitis in rats during the initial experimental period.O objetivo deste trabalho foi avaliar o efeito de um inibidor seletivo da cicloxigenase-2 (COX-2) (meloxicam) na progressão da perda óssea alveolar durante o desenvolvimento da doença periodontal experimental induzida. Quarenta (40) ratos Wistar foram separados em 8 grupos experimentais (n = 5). Ligaduras de fio de algodão foram colocadas na margem gengival do primeiro molar inferior direito de alguns ratos. Quatro grupos foram tratados por 5 ou 15 dias com uma dose oral de 15 mg/kg de peso corporal/dia do inibidor seletivo de COX-2. Os outros grupos foram usados como controle positivo (sham) e controle negativo dentro de cada período experimental. Radiografias digitais padronizadas foram realizadas para medir a perda óssea na região mesial do primeiro molar inferior de cada rato. O efeito do tratamento com meloxicam não induziu alteração de peso ou outras manifestações sistêmicas visíveis. A Análise de Variância (ANOVA) indicou que os grupos tratados com meloxicam após 5 dias apresentaram perda óssea alveolar significativamente menor (p < 0,05). Por outro lado, a perda óssea não foi significativa após 15 dias de tratamento com meloxicam. Os dados apresentados no presente trabalho sugerem que o tratamento sistêmico com meloxicam pode modificar a progressão da periodontite experimental em ratos no período experimental inicial.Universidade Federal do Paraná, School of Dentistry of CascavelSão Paulo State University, School of Dentistry of AraraquaraEducational Foundation of Barretos, School of PharmacologySão Paulo State University, School of Dentistry of AraraquaraSociedade Brasileira de Pesquisa Odontológica - SBPqOUniversidade Federal do ParanáUniversidade Estadual Paulista (Unesp)Educational Foundation of BarretosNassar, Carlos AugustoNassar, Patrícia OehlmeyerNassar, Patrícia MariaSpolidorio, Luis Carlos [UNESP]2021-07-14T10:50:28Z2021-07-14T10:50:28Z2005-03info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article36-40application/pdfhttp://dx.doi.org/10.1590/S1806-83242005000100007Brazilian Oral Research. São Paulo, SP, Brazil: Sociedade Brasileira de Pesquisa Odontológica - SBPqO, v. 19, n. 1, p. 36-40, 2005.1806-83241807-3107http://hdl.handle.net/11449/21312810.1590/S1806-83242005000100007S1806-83242005000100007S1806-83242005000100007.pdfSciELOreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBrazilian Oral Researchinfo:eu-repo/semantics/openAccess2024-09-27T14:04:56Zoai:repositorio.unesp.br:11449/213128Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-27T14:04:56Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Selective cyclooxygenase-2 inhibition prevents bone resorption
Inibidor seletivo de cicloxigenase-2 prevenindo reabsorção óssea
title Selective cyclooxygenase-2 inhibition prevents bone resorption
spellingShingle Selective cyclooxygenase-2 inhibition prevents bone resorption
Nassar, Carlos Augusto
Alveolar bone loss
Anti-inflammatory agents, non-steroidal
Cyclooxygenase inhibitors
Periodontitis
Radiography, dental
Perda óssea alveolar
Antiinflamatórios não esteróides
Inibidores de ciclooxigenase
Periodontite
Radiografia dentária
title_short Selective cyclooxygenase-2 inhibition prevents bone resorption
title_full Selective cyclooxygenase-2 inhibition prevents bone resorption
title_fullStr Selective cyclooxygenase-2 inhibition prevents bone resorption
title_full_unstemmed Selective cyclooxygenase-2 inhibition prevents bone resorption
title_sort Selective cyclooxygenase-2 inhibition prevents bone resorption
author Nassar, Carlos Augusto
author_facet Nassar, Carlos Augusto
Nassar, Patrícia Oehlmeyer
Nassar, Patrícia Maria
Spolidorio, Luis Carlos [UNESP]
author_role author
author2 Nassar, Patrícia Oehlmeyer
Nassar, Patrícia Maria
Spolidorio, Luis Carlos [UNESP]
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade Federal do Paraná
Universidade Estadual Paulista (Unesp)
Educational Foundation of Barretos
dc.contributor.author.fl_str_mv Nassar, Carlos Augusto
Nassar, Patrícia Oehlmeyer
Nassar, Patrícia Maria
Spolidorio, Luis Carlos [UNESP]
dc.subject.por.fl_str_mv Alveolar bone loss
Anti-inflammatory agents, non-steroidal
Cyclooxygenase inhibitors
Periodontitis
Radiography, dental
Perda óssea alveolar
Antiinflamatórios não esteróides
Inibidores de ciclooxigenase
Periodontite
Radiografia dentária
topic Alveolar bone loss
Anti-inflammatory agents, non-steroidal
Cyclooxygenase inhibitors
Periodontitis
Radiography, dental
Perda óssea alveolar
Antiinflamatórios não esteróides
Inibidores de ciclooxigenase
Periodontite
Radiografia dentária
description The aim of the present work was to evaluate the effect of a selective cyclooxygenase-2 (COX-2) inhibitor (meloxicam) on the alveolar bone loss progression in experimentally induced periodontitis. Forty (40) Wistar rats were separated into 8 experimental groups (n = 5). Cotton ligatures were placed at the gingival margin level of the lower right first molars of some rats. Four groups were treated for 5 or 15 days with an oral dose of 15 mg/kg of body weight/day of the selective COX-2 inhibitor. The other groups were used as positive control (sham) or negative control in each experimental period. Standardized digital radiographs were taken after sacrifice at 5 and 15 days to measure the amount of bone loss at the mesial root surface of the first molar tooth in each rat. The treatment with meloxicam did not induce weight alteration or other visible systemic manifestations. One way analysis of variance (ANOVA) indicated that groups treated with meloxicam, after 5 days, had significantly less alveolar bone loss (p < 0.05) when compared with control groups. On the other hand, no significant differences in bone loss were observed after 15 days of treatment with meloxicam. These data provide evidence that systemic therapy with meloxicam can modify the progression of experimentally induced periodontitis in rats during the initial experimental period.
publishDate 2005
dc.date.none.fl_str_mv 2005-03
2021-07-14T10:50:28Z
2021-07-14T10:50:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S1806-83242005000100007
Brazilian Oral Research. São Paulo, SP, Brazil: Sociedade Brasileira de Pesquisa Odontológica - SBPqO, v. 19, n. 1, p. 36-40, 2005.
1806-8324
1807-3107
http://hdl.handle.net/11449/213128
10.1590/S1806-83242005000100007
S1806-83242005000100007
S1806-83242005000100007.pdf
url http://dx.doi.org/10.1590/S1806-83242005000100007
http://hdl.handle.net/11449/213128
identifier_str_mv Brazilian Oral Research. São Paulo, SP, Brazil: Sociedade Brasileira de Pesquisa Odontológica - SBPqO, v. 19, n. 1, p. 36-40, 2005.
1806-8324
1807-3107
10.1590/S1806-83242005000100007
S1806-83242005000100007
S1806-83242005000100007.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brazilian Oral Research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 36-40
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Pesquisa Odontológica - SBPqO
publisher.none.fl_str_mv Sociedade Brasileira de Pesquisa Odontológica - SBPqO
dc.source.none.fl_str_mv SciELO
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1813546416975380480